GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ScandiDos AB (OSTO:SDOS) » Definitions » Cyclically Adjusted Price-to-FCF

ScandiDos AB (OSTO:SDOS) Cyclically Adjusted Price-to-FCF : (As of Jun. 06, 2025)


View and export this data going back to 2014. Start your Free Trial

What is ScandiDos AB Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


ScandiDos AB Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for ScandiDos AB's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ScandiDos AB Cyclically Adjusted Price-to-FCF Chart

ScandiDos AB Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

ScandiDos AB Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of ScandiDos AB's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, ScandiDos AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ScandiDos AB's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ScandiDos AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where ScandiDos AB's Cyclically Adjusted Price-to-FCF falls into.


;
;

ScandiDos AB Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

ScandiDos AB's Cyclically Adjusted FCF per Share for the quarter that ended in Jan. 2025 is calculated as:

For example, ScandiDos AB's adjusted Free Cash Flow per Share data for the three months ended in Jan. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Jan. 2025 (Change)*Current CPI (Jan. 2025)
=0.02/132.9426*132.9426
=0.020

Current CPI (Jan. 2025) = 132.9426.

ScandiDos AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201504 -0.105 99.941 -0.140
201507 -0.463 100.027 -0.615
201510 -0.389 100.301 -0.516
201601 0.075 99.931 0.100
201604 -0.349 100.732 -0.461
201607 -0.316 101.080 -0.416
201610 -0.130 101.485 -0.170
201701 -0.070 101.326 -0.092
201704 -0.228 102.615 -0.295
201707 -0.073 103.301 -0.094
201710 -0.219 103.202 -0.282
201801 -0.113 102.925 -0.146
201804 -0.042 104.390 -0.053
201807 -0.166 105.420 -0.209
201810 -0.289 105.545 -0.364
201901 -0.098 104.855 -0.124
201904 -0.235 106.627 -0.293
201907 -0.023 107.166 -0.029
201910 -0.116 107.243 -0.144
202001 -0.036 106.215 -0.045
202004 -0.064 106.240 -0.080
202007 0.159 107.731 0.196
202010 0.005 107.539 0.006
202101 -0.091 107.897 -0.112
202104 0.018 108.624 0.022
202107 0.025 109.218 0.030
202110 -0.060 110.562 -0.072
202201 -0.117 111.876 -0.139
202204 0.102 115.534 0.117
202207 -0.140 118.489 -0.157
202210 -0.221 122.561 -0.240
202301 -0.022 124.942 -0.023
202304 -0.006 127.632 -0.006
202307 -0.135 129.464 -0.139
202310 0.101 130.549 0.103
202401 -0.010 131.720 -0.010
202404 -0.001 132.601 -0.001
202407 -0.007 132.831 -0.007
202410 -0.168 132.604 -0.168
202501 0.020 132.943 0.020

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


ScandiDos AB  (OSTO:SDOS) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


ScandiDos AB Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of ScandiDos AB's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


ScandiDos AB Business Description

Traded in Other Exchanges
N/A
Address
Uppsala Science Park, Uppsala, SWE, S-751 83
ScandiDos AB is a Sweden based company involved in providing Radiation Therapy. It provides measurement systems and software that are designed for QA and validation of treatments that are being implemented in clinics around the world.

ScandiDos AB Headlines

No Headlines